Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders

References

• APA (American Psychiatric Association). 1980. Diagnostic and statistical manual of mental disorders,3rd ed. Washington, DC: American Psychiatric Press.
   Google Scholar
• Bakker A, van Dyck R, Spinhoven P, van Balkom A. Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder. J Clin Psychiatry 1999; 60: 831–838
   PubMed Web of Science ®Google Scholar
• Baldwin DS, Anderson IM, Nutt DJ, Bandelow B, Bond A, Davidson JR, den Boer JA, Fineberg NA, Knapp M, Scott J, Wittchen HU. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2005; 19: 567–596
   PubMed Web of Science ®Google Scholar
• Bandelow B, Haug TT. Sertraline and exposure therapy in social phobia (author's reply). Br J Psychiatry 2004; 184: 271–272
   Google Scholar
• Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders. World J Biol Psychiatry 2002; 3: 171–199
   PubMedGoogle Scholar
• Barlow DH, Gorman JM, Shear MK, Woods SW. Cognitive-behavioural therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. J Am Med Assoc 2000; 283: 2529–2536
   PubMed Web of Science ®Google Scholar
• Beck AT, Sokol L, Clark DA, Berchick R, Wright F. A crossover study of focused cognitive therapy for panic disorder. Am J Psychiatry 1992; 149: 778–783
   PubMed Web of Science ®Google Scholar
• Black DW, Wesner R, Bowers W, Gabel J. A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder. Arch Gen Psychiatry 1993; 50: 44–50
   PubMed Web of Science ®Google Scholar
• Blomhoff S, Tangen Haug T, Hellstrom K, Holme I, Humble M, Madsbu HP, Wold JE. Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia. Br J Psychiatry 2001; 179: 23–30
   PubMed Web of Science ®Google Scholar
• Borden JW, Clum GA, Salmon PG. Mechanisms of change in the treatment of panic. Cogn Ther Res 1991; 15: 257–272
   Web of Science ®Google Scholar
• Bouchard S, Gauthier J, Laberge B, French D, Pelletier MH, Godbout C. Exposure versus cognitive restructuring in the treatment of panic disorder with agoraphobia. Behav Res Ther 1996; 34: 213–224
   PubMed Web of Science ®Google Scholar
• Bradwejn J, Koszicki D, Segal Z. 2005. Randomized trial of acute and extension treatment with sertraline, self-administered cognitive behaviour therapy, alone or in combination, for panic disorder. Poster, European College of Neuropsychopharmacology (ECNP) Congress, Amsterdam.
   Google Scholar
• Brown GK, Beck AT, Newman CF, Beck JS, Tran GQ. A comparison of focused and standard cognitive therapy for panic disorder. J Anxiety Disord 1997; 11: 329–345
   PubMed Web of Science ®Google Scholar
• Clark DM, Salkovskis PM, Hackmann A, Middleton H, Anastasiades P, Gelder M. A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. Br J Psychiatry 1994; 164: 759–769
   PubMed Web of Science ®Google Scholar
• Clark DM, Ehlers A, McManus F, Hackmann A, Fennell M, Campbell H, Flower T, Davenport C, Louis B. Cognitive therapy versus fluoxetine in generalized social phobia: a randomized placebo-controlled trial. J Consult Clin Psychol 2003; 71: 1058–1067
   PubMed Web of Science ®Google Scholar
• Clum GA, Clum GA, Surls R. A meta-analysis of treatments for panic disorder. J Consult Clin Psychol 1993; 61: 317–326
   PubMed Web of Science ®Google Scholar
• Cohen J. 1988. Statistical power analysis for the behavioural sciences.2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates.
   Google Scholar
• Cohen SD, Monteiro W, Marks IM. Two-year follow-up of agoraphobics after exposure and imipramine. Br J Psychiatry 1984; 144: 276–281
   PubMed Web of Science ®Google Scholar
• Côté G, Gauthier J, Laberge B, Cormier H. Reduced therapist contact in the cognitive behavioural treatment of panic disorder. Behav Ther 1994; 25: 123–145
   Google Scholar
• Cottraux J, Note ID, Cungi C, Legeron P, Heim F, Chneiweiss L, Bernard G, Bouvard M. A controlled study of cognitive behaviour therapy with buspirone or placebo in panic disorder with agoraphobia. Br J Psychiatry 1995; 167: 635–641
   PubMedGoogle Scholar
• Cox B, Swinson R, Lee P. Meta-analysis of anxiety disorder treatment studies. J Clin Psychopharmacol 1992a; 12: 300–301
   Google Scholar
• Cox BJ, Endler NS, Lee PS, Swinson RP. A meta-analysis of treatments for panic disorder with agoraphobia: imipramine, alprazolam, and in vivo exposure. J Behav Ther Exp Psychiatry 1992b; 23: 175–182
   PubMedGoogle Scholar
• Craske MG, Street L, Barlow DH. Instructions to focus upon or distract from internal cues during exposure treatment of agoraphobic avoidance. Behav Res Ther 1989; 27: 663–672
   PubMedGoogle Scholar
• Craske MG, Rowe M, Lewin M, Noriega-Dimitri R. Interoceptive exposure versus breathing retraining within cognitive-behavioural therapy for panic disorder with agoraphobia. Br J Clin Psychol 1997; 36: 85–99
   PubMed Web of Science ®Google Scholar
• Davidson JR, Foa EB, Huppert JD, Keefe FJ, Franklin ME, Compton JS, Zhao N, Connor KM, Lynch TR, Gadde KM. Fluoxetine, comprehensive cognitive behavioural therapy, and placebo in generalized social phobia. Arch Gen Psychiatry 2004; 61: 1005–1013
   PubMed Web of Science ®Google Scholar
• de Beurs E, van Balkom AJ, Lange A, Koele P, van Dyck R. Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone. Am J Psychiatry 1995; 152: 683–691
   PubMed Web of Science ®Google Scholar
• DiNardo PA, GT OB, Barlow DH, Waddell MT, Blanchard EB. 1983. Reliability of DSM-III anxiety disorder categories using a new structured interview. Arch Gen Psychiatry 40:1070–1074.
   PubMed Web of Science ®Google Scholar
• Falloon IRH, Lloyd GG, Harpin RE. The treatment of social phobia. J Nerv Ment Dis 1981; 169: 180–184
   PubMed Web of Science ®Google Scholar
• Fedoroff IC, Taylor S. Psychological and pharmacological treatments of social phobia: a meta-analysis. J Clin Psychopharmacol 2001; 21: 311–324
   PubMed Web of Science ®Google Scholar
• Foa EB. 2000. Psychosocial treatment of posttraumatic stress disorder. J Clin Psychiatry 61(Suppl 5):43–48; discussion 49–51.
   PubMed Web of Science ®Google Scholar
• Gelernter CS, Uhde TW, Cimbolic P, Arnkoff DB, Vittone BJ, Tancer ME, Bartko JJ. Cognitive-behavioural and pharmacological treatments of social phobia. A controlled study. Arch Gen Psychiatry 1991; 48: 938–945
   PubMed Web of Science ®Google Scholar
• Gould RA, Clum GA. Self-help plus minimal therapist contact in the treatment of panic disorder: a replication and extension. Behav Ther 1995; 24: 241–252
   Google Scholar
• Gould RA, Clum GA, Shapiro D. The use of bibliotherapy in the treatment of panic: a preliminary investigation. Behav Ther 1993; 24: 241–252
   Web of Science ®Google Scholar
• Gould RA, Otto MW, Pollack MH. A meta-analysis of treatment outcome for panic disorder. Clin Psychol Rev 1995; 15: 819–844
   Web of Science ®Google Scholar
• Gould RA, Buckminster S, Pollack MH, Otto MW, Yap L. Cognitive-behavioural and pharmacological treatment for social phobia: A meta-analysis. Clin Psychol Sci Pract 1997; 4: 291–306
   Web of Science ®Google Scholar
• Guy W. 1976. Clinical Global Impression Scale (CGI). ECDEU assessment manual for psychopharmacology. Washington, DC: National Institute of Mental Health, US Department of Health, Education, and Welfare publication (ADM). pp 76–338.
   Google Scholar
• Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32: 50–55
   PubMed Web of Science ®Google Scholar
• Haug TT, Blomhoff S, Hellstrom K, Holme I, Humble M, Madsbu HP, Wold JE. Exposure therapy and sertraline in social phobia: I-year follow-up of a randomised controlled trial. Br J Psychiatry 2003; 182: 312–318
   PubMed Web of Science ®Google Scholar
• Heimberg RG, Liebowitz MR, Hope DA, Schneier FR, Holt CS, Welkowitz LA, Juster HR, Campeas R, Bruch MA, Cloitre M, Fallon B, Klein DF. Cognitive behavioural group therapy vs phenelzine therapy for social phobia: 12-week outcome. Arch Gen Psychiatry 1998; 55: 1133–1141
   PubMed Web of Science ®Google Scholar
• Kampman M, Keijsers GP, Hoogduin CA, Hendriks GJ. A randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioural therapy alone. J Clin Psychiatry 2002; 63: 772–777
   PubMed Web of Science ®Google Scholar
• Klein DF. Flawed meta-analyses comparing psychotherapy with pharmacotherapy. Am J Psychiatry 2000; 157: 1204–1211
   PubMed Web of Science ®Google Scholar
• Klosko JS, Barlow DH, Tassinari R, Cerny JA. A comparison of alprazolam and behavior therapy in treatment of panic disorder. J Consult Clin Psychol 1990; 58: 77–84
   PubMed Web of Science ®Google Scholar
• Lader MH, Bond AJ. Interaction of pharmacological and psychological treatments of anxiety. Br J Psychiatry 1998; 173: 42–48
   Google Scholar
• Lambert MJ, Hatch DR, Kingston MD, Edwards BC. Zung, Beck, and Hamilton Rating Scales as measures of treatment outcome: a meta-analytic comparison. J Consult Clin Psychol 1986; 54: 54–59
   PubMed Web of Science ®Google Scholar
• Lidren DM, Watkins PL, Gould RA, Clum GA, Asterino M, Tulloch HL. A comparison of bibliotherapy and group therapy in the treatment of panic disorder. J Consult Clin Psychol 1994; 62: 865–869
   PubMedGoogle Scholar
• Liebowitz MR, Heimberg RG, Schneier FR, Hope DA, Davies S, Holt CS, Goetz D, Juster HR, Lin SH, Bruch MA, Marshall RD, Klein DF. Cognitive-behavioural group therapy versus phenelzine in social phobia: long-term outcome. Depress Anxiety 1999; 10: 89–98
   PubMed Web of Science ®Google Scholar
• Lindsay WR, Gamsu CV, McLaughlin E, Hood EM, Espie CA. A controlled trial of treatments for generalized anxiety. Br J Clin Psychol 1987; 26: 3–15
   PubMed Web of Science ®Google Scholar
• Loerch B, Graf-Morgenstern M, Hautzinger M, Schlegel S, Hain C, Sandmann J, Benkert O. Randomised placebo-controlled trial of moclobemide, cognitive- behavioural therapy and their combination in panic disorder with agoraphobia. Br J Psychiatry 1999; 174: 205–212
   PubMed Web of Science ®Google Scholar
• Margraf J, Barlow DH, Clark DM, Telch MJ. Psychological treatment of panic: work in progress on outcome, active ingredients, and follow-up. Behav Res Ther 1993; 31: 1–8
   PubMed Web of Science ®Google Scholar
• Marks IM, Matthews AM. Brief standard self-rating for phobic patients. Behav Res Ther 1979; 17: 263–267
   PubMed Web of Science ®Google Scholar
• Marks IM, Gray S, Cohen D, Hill R, Mawson D, Ramm E, Stern RS. Imipramine and brief therapists-aided exposure in agoraphobics having self-exposure homework. Arch Gen Psychiatry 1983; 40: 153–162
   PubMed Web of Science ®Google Scholar
• Marks IM, Swinson RP, Basoglu M, Kuch K, Noshirvani H, OS G, Lelliott PT, Kirby M, McNamee G, Sengun S, Wickwire K. 1993. Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto. Br J Psychiatry 162:776–787.
   PubMed Web of Science ®Google Scholar
• Mattick RP, Andrews G, Hadzi-Pavlovic D, Christensen H. Treatment of panic and agoraphobia. An integrative review. J Nerv Ment Dis 1990; 178: 567–576
   PubMed Web of Science ®Google Scholar
• Mavissakalian M, Michelson L, Dealy RS. Pharmacological treatment of agoraphobia: imipramine versus imipramine with programmed practice. Br J Psychiatry 1983a; 143: 348–355
   PubMed Web of Science ®Google Scholar
• Mavissakalian M, Michelson L, Greenwald D, Kornblith S, Greenwald M. Cognitive-behavioural treatment of agoraphobia – paradoxical invention vs self-statement training. Behav Res Ther 1983b; 21: 75–86
   PubMed Web of Science ®Google Scholar
• Mavissakalian M, Michelson L. Agoraphobia – relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine. J Clin Psychiatr 1986; 47: 117–122
   PubMed Web of Science ®Google Scholar
• McNamee R, O'Sullivan G, Lelliott P, Marks I. Telephone-guided treatment for housebound agoraphobics with panic disorder – exposure vs relaxation. Behav Ther 1989; 20: 491–497
   Web of Science ®Google Scholar
• Mitte K. A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia. J Affect Disord 2005; 88: 27–45
   PubMed Web of Science ®Google Scholar
• Newman MG, Kenardy J, Herman S, Taylor CB. Comparison of palmtop-computer-assisted brief cognitive-behavioural treatment to cognitive-behavioural treatment for panic disorder. J Consult Clin Psychol 1997; 65: 178–183
   PubMed Web of Science ®Google Scholar
• Oehrberg S, Christiansen PE, Behnke K, Borup AL, Severin B, Soegaard J, Calberg H, Judge R, Ohrstrom JK, Manniche PM. Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study. Br J Psychiatry 1995; 167: 374–379
   PubMed Web of Science ®Google Scholar
• Öst LG, Westling BE. Applied relaxation vs cognitive behavior therapy in the treatment of panic disorder. Behav Res Ther 1995; 33: 145–158
   PubMed Web of Science ®Google Scholar
• Öst LG, Westling BE, Hellstrom K. 1993. Applied relaxation, exposure in vivo and cognitive 394.
   Google Scholar
• Otto MW, Pollack MH, Gould RA, Worthington JJ, 3rd, McArdle ET, Rosenbaum JF. A comparison of the efficacy of clonazepam and cognitive-behavioural group therapy for the treatment of social phobia. J Anxiety Disord 2000; 14: 345–358
   PubMed Web of Science ®Google Scholar
• Power KG, Simpson RJ, Swanson V, Wallace LA. Controlled comparison of pharmacological and psychological treatment of generalized anxiety disorder in primary care. Br J Gen Pract 1990; 40: 289–294
   PubMed Web of Science ®Google Scholar
• Rosenthal R. Meta-analytic procedures for social research: Applied social research methods. Sage Publications, Newbury Park, CA 1991
   Google Scholar
• Shadish WR, Haddock CK. Combining estimates of effect size. The handbook of research synthesis, H Cooper, LV Hedges. Russel Sage, New York 1994; 261–281
   Google Scholar
• Sharp DM, Power KG, Simpson RJ, Swanson V, Anstee JA. Global measures of outcome in a controlled comparison of pharmacological and psychological treatment of panic disorder and agoraphobia in primary care. Br J Gen Pract 1997; 47: 150–155
   PubMed Web of Science ®Google Scholar
• Sheehan DV. The anxiety disease. Charles Scribner's Sons, New York 1983
   Google Scholar
• Stein MB, Ron Norton G, Walker JR, Chartier MJ, Graham R. Do selective serotonin re-uptake inhibitors enhance the efficacy of very brief cognitive behavioural therapy for panic disorder? A pilot study. Psychiatry Res 2000; 94: 191–200
   PubMed Web of Science ®Google Scholar
• Swinson RP, Fergus KD, Cox BJ, Wickwire K. Efficacy of telephone-administered behavioural therapy for panic disorder with agoraphobia. Behav Res Ther 1995; 33: 465–469
   PubMed Web of Science ®Google Scholar
• Telch M, Agras W, Taylor C, Roth W, Gallen C. Combined pharmacological and behavioural treatment for agoraphobia. Behav Res Ther 1985; 23: 325–335
   PubMed Web of Science ®Google Scholar
• Telch MJ, Lucas JA, Schmidt NB, Hanna HH, LaNae Jaimez T, Lucas RA. Group cognitive-behavioural treatment of panic disorder. Behav Res Ther 1993; 31: 279–287
   PubMed Web of Science ®Google Scholar
• Telch MJ, Schmidt NB, Jaimez TL, Jacquin KM, Harrington PJ. Impact of cognitive-behavioural treatment on quality of life in panic disorder patients. J Consult Clin Psychol 1995; 63: 823–830
   PubMedGoogle Scholar
• Turner SM, Beidel DC, Jacob RG. Social phobia: a comparison of behavior therapy and atenolol. J Consult Clin Psychol 1994; 62: 350–358
   PubMed Web of Science ®Google Scholar
• van Balkom AJ, Bakker A, Spinhoven P, Blaauw BM, Smeenk S, Ruesink B. A meta-analysis of the treatment of panic disorder with or without agoraphobia: a comparison of psychopharmacological, cognitive-behavioural, and combination treatments. J Nerv Ment Dis 1997; 185: 510–516
   PubMedGoogle Scholar
• Watson D, Friend R. Measurement of social-evaluative anxiety. J Consult Clin Psychol 1969; 33: 448–457
   PubMed Web of Science ®Google Scholar
• Westen D, Morrison K. A multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: an empirical examination of the status of empirically supported therapies. J Consult Clin Psychol 2001; 69: 875–899
   PubMed Web of Science ®Google Scholar
• Williams SL, Falbo J. Cognitive and performance-based treatments for panic attacks in people with varying degrees of agoraphobic disability. Behav Res Ther 1996; 34: 253–264
   PubMed Web of Science ®Google Scholar
• Zitrin CM, Klein DF, Woerner MG. Treatment of agoraphobia with group exposure in vivo and imipramine. Arch Gen Psychiatry 1980; 37: 63–72
   PubMed Web of Science ®Google Scholar
• Zitrin CM, Klein DF, Woerner MG, Ross DC. Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo. Arch Gen Psychiatry 1983; 40: 125–138
   PubMed Web of Science ®Google Scholar